文献速递系统性红斑狼疮

系统性红斑狼疮孕妇妊娠期高血压疾病与远期心血管结局

Maternal Hypertensive Disorders in Pregnant Women With Systemic Lupus Erythematosus and Future Cardiovascular Outcomes.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-01-01

基于人群队列研究(1987-2012年医疗出生登记)发现,SLE孕妇妊娠期高血压疾病(HDPs)发生率20%高于非SLE孕妇的7%。在SLE孕妇中,HDPs与心血管结局风险增加2倍、新发高血压风险增加3倍相关,且HDPs介导了SLE与高血压关联的20%。

要点

  • SLE孕妇HDPs发生率20%,显著高于非SLE孕妇的7%。
  • SLE合并HDPs者心血管结局风险增加2倍,新发高血压风险增加3倍。
  • HDPs介导了SLE与高血压关联的20%,提示其部分解释SLE心血管风险。

核心结论

  • 在SLE和非SLE孕妇中,HDPs均与高血压风险增加3倍相关;在SLE中,HDPs者心血管结局发生率为无HDPs者的2倍。

研究设计与样本

  • 基于人群的队列研究,识别医疗出生登记(1987-2012年)中SLE母亲和一般人群比较组的首次单胎出生。

主要发现

  • SLE孕妇HDPs发生率为20%,非SLE孕妇为7%。
  • SLE孕妇中,HDPs与心血管结局风险增加2倍和新发高血压风险增加3倍相关。
  • HDPs介导了SLE与高血压关联的20%。
  • 非SLE孕妇中,HDPs与晚年高血压发生率升高相关。

关键数值与推荐

  • HDPs、心血管结局和高血压的诊断通过国际疾病分类编码从国家患者登记中识别。
  • 使用调整风险比和95%置信区间评估关联,采用相对超额风险交互和Cox模型评估相加和相乘效应修饰。

临床怎么用

  • SLE孕妇应重视HDPs的筛查与管理,以降低远期心血管结局和高血压风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hypertensive disorders of pregnancy (HDPs) increase cardiovascular disease (CVD) risk. Pregnancy morbidities, including preeclampsia and CVD, are common in systemic lupus erythematosus (SLE). Possible connections are important to explore. In a population-based cohort, we investigated whether HDPs are associated with a higher risk of cardiovascular outcomes separately in women with SLE and those without SLE to examine the role of SLE. METHODS: We identified first singleton births in the Medical Birth Register (1987-2012) among mothers with SLE and a large general population comparison group. Discharge diagnoses for HDPs, cardiovascular outcomes, and hypertension in the National Patient Register were identified using International Classification of Diseases codes. We estimated adjusted hazard ratios and 95% confidence intervals of the association between HDPs and outcomes in separate models in women with and without SLE. We then evaluated additive and multiplicative effect modification using relative excess risk due to interaction and Cox models jointly accounting for SLE and HDPs, respectively. Mediation analysis estimated the proportion of the association between SLE and outcome explained by HDPs. RESULTS: HDPs were more common in pregnant women with SLE (20% versus 7%). In SLE, HDPs were associated with a 2-fold higher rate of cardiovascular outcomes and a 3-fold higher rate of incident hypertension. HDPs mediated 20% of the latter association. In women without SLE, HDPs were associated with higher incidence of hypertension later in life. CONCLUSION: In women with SLE and those without SLE, HDPs were associated with a 3-fold higher rate of hypertension. In SLE, women with HDPs developed cardiovascular outcomes twice as often as women without HDPs.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Simard JF, Rossides M, Arkema EV, et al. Maternal Hypertensive Disorders in Pregnant Women With Systemic Lupus Erythematosus and Future Cardiovascular Outcomes. Arthritis Care Res (Hoboken). 2021. PMID: 32004410. doi:10.1002/acr.24160

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。